Fabian Theis expects generative models and molecule-level lab-in-the-loop approaches to scale up to work at the cell level.

“I do think that there's a whole bunch of reasons why we're gonna see that sort of scale up from all these models working well in terms of being generative, but also sort of lab in the loop on the molecule level now being exported and sort of really working one level up on, on, on the cell level.”